Kidney-Targeted Redox Scavenger Therapy Prevents Cisplatin-Induced Acute Kidney Injury

Cisplatin-induced acute kidney injury (CI-AKI) is a significant co-morbidity of chemotherapeutic regimens. While this condition is associated with substantially lower survival and increased economic burden, there is no pharmacological agent to effectively treat CI-AKI. The disease is hallmarked by a...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ryan M. Williams, Janki Shah, Elizabeth Mercer, Helen S. Tian, Vanessa Thompson, Justin M. Cheung, Madeline Dorso, Jaclyn M. Kubala, Lorraine J. Gudas, Elisa de Stanchina, Edgar A. Jaimes, Daniel A. Heller
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2022-01-01
Saila:	Frontiers in Pharmacology
Gaiak:	nanomedicine pharmacology acute kidney injury drug repurposing cisplatin redox scavenger
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fphar.2021.790913/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!